Precision Biosciences (DTIL) EBIT Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 1,386.07% |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | 58.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.96% |
| Dec 31, 2025 | 150.34% |
| Sep 30, 2025 | 2.86% |
| Jun 30, 2025 | -190.60% |
| Mar 31, 2025 | -428.11% |
| Dec 31, 2024 | -66.86% |
| Sep 30, 2024 | -72.09% |
| Jun 30, 2024 | 871.68% |
| Mar 31, 2024 | 68.65% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 89.41% |
| Mar 31, 2023 | 51.15% |
| Dec 31, 2022 | 60.59% |
| Sep 30, 2022 | -27.15% |
| Jun 30, 2022 | -236.62% |
| Mar 31, 2022 | -45.85% |
| Dec 31, 2021 | -30.85% |
| Sep 30, 2021 | 55.68% |
| Jun 30, 2021 | 165.94% |